You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Eating Chocolate May Decrease Risk for Preeclampsia

  • Authors: News Author: Laurie Barclay, MD
    CME Author: Laurie Barclay, MD
  • CME/CE Released: 5/2/2008
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 5/2/2009, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians, obstetricians, and other specialists who care for pregnant women at risk for preeclampsia.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Describe the association between preeclampsia and theobromine concentration (as a marker of chocolate consumption) in umbilical cord serum.
  2. Describe the association between preeclampsia and self-reported chocolate consumption during pregnancy.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Laurie Barclay, MD

    Laurie Barclay, MD, is a freelance reviewer and writer for Medscape.

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor(s)

  • Brande Nicole Martin

    Brande Nicole Martin is the News CME editor for Medscape Medical News.

    Disclosures

    Disclosure: Brande Nicole Martin has disclosed no relevant financial information.

CME Author(s)

  • Laurie Barclay, MD

    Freelance reviewer and writer for Medscape

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.


    AAFP Accreditation Questions

    Contact This Provider

    For Nurses

  • This Activity is sponsored by Medscape Continuing Education Provider Unit.

    Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; None of these credits is in the area of pharmacology.

    Provider Number: 6FDKKC-PRV-05

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

Eating Chocolate May Decrease Risk for Preeclampsia

Authors: News Author: Laurie Barclay, MD CME Author: Laurie Barclay, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 5/2/2008

Valid for credit through: 5/2/2009, 11:59 PM EST

processing....

May 2, 2008 — Chocolate may decrease the risk for preeclampsia, according to the results of a prospective cohort study reported in the May issue of Epidemiology.

"Preeclampsia is a major pregnancy complication with cardiovascular manifestations," write Elizabeth W. Triche, PhD, from the Yale Center for Perinatal, Pediatric and Environmental Epidemiology in New Haven, Connecticut, and colleagues. "Recent studies suggest that chocolate consumption may benefit cardiovascular health."

The study sample used to evaluate the association of chocolate consumption with the risk for preeclampsia consisted of 2291 pregnant women who delivered a singleton live birth between September 1996 and January 2000.

The investigators measured chocolate consumption by self-report in the first and third trimesters and by umbilical cord serum concentrations of theobromine, which is the main methylxanthine component of chocolate. Detailed medical record review for 1943 of the women allowed determination of preeclampsia. Logistic regression models controlling for potential confounders were used to determine adjusted odds ratios (aOR) and 95% confidence intervals (CIs).

Of 1681 women, preeclampsia developed in 63 (3.7%). Umbilical cord serum theobromine concentrations were inversely associated with preeclampsia (for the highest vs the lowest quartile [aOR, 0.31; CI, 0.11 - 0.87]).

Self-reported estimates of chocolate consumption were also negatively associated with preeclampsia. The risk for preeclampsia was decreased for women consuming 5 or more servings per week vs women consuming less than 1 serving of chocolate weekly (aOR, 0.81; CI, 0.37 - 1.79 for consumption in the first 3 months of pregnancy and aOR, 0.60; CI, 0.30 - 1.24 in the last 3 months).

"Our results suggest that chocolate consumption during pregnancy may lower risk of preeclampsia," the study authors write. "However, reverse causality may also contribute to these findings."

Limitations of this study include difficulty standardizing self-reported chocolate consumption, possible reverse causality if women diagnosed with preeclampsia reduced their calorie intake after diagnosis, possible residual confounding by smoking or body mass index (BMI), small number of women with preeclampsia, and potential misclassification of exposure.

"Because of the importance of preeclampsia as a major complication of pregnancy, replication of these results in other large prospective studies with a detailed assessment of chocolate consumption is warranted," the study authors write. "Measurements of chocolate exposure should be designed to permit careful examination of the temporal relationship between chocolate consumption in pregnancy and subsequent risk of preeclampsia."

The National Institute on Drug Abuse supported this study.

Epidemiology. 2008;19:459-464.

Clinical Context

Chocolate contains more than 600 beneficial compounds including flavonoids, magnesium, and theobromine, and recent research suggests that chocolate, particularly dark chocolate, may benefit cardiovascular health. The potent antioxidants in flavonoids can induce nitric oxide–dependent vasodilation and also have antiplatelet and anti-inflammatory effects.

Preeclampsia is a serious maternal complication of pregnancy that shares many characteristics and risk factors for cardiovascular disease. The purpose of this study was to determine whether chocolate consumption is associated with preeclampsia.

Study Highlights

  • Pregnant women were recruited from September 1996 to January 2000 from 56 obstetric practices and 15 clinics associated with 6 hospitals in Connecticut and Massachusetts.
  • Exclusion criteria were more than 24 weeks' gestational age at enrollment, insulin-dependent diabetes mellitus, non-English or Spanish-speaking women, or intention to terminate the pregnancy.
  • Of 11,267 women screened for the study, 9576 met eligibility criteria, and 3631 women were invited to participate, of whom 2478 (68%) enrolled, 639 (18%) declined, 424 (12%) were lost to follow-up, 72 (2%) had a miscarriage before enrollment, and 20 (< 1%) were not eligible at enrollment interview.
  • Of the 2478 enrolled women, 2291 (92%) delivered a singleton infant live birth.
  • The investigators measured chocolate consumption by self-report in the first and third trimesters and by umbilical cord serum concentrations of theobromine (the main methylxanthine component of chocolate).
  • Umbilical cord blood biomarker data were available for 1611 infants, 1995 women provided data on both first-trimester and third-trimester chocolate consumption, and preeclampsia status was determined for 1943 women from detailed medical record review.
  • Logistic regression models controlling for potential confounders were used to determine aORs and 95% CIs.
  • Reported chocolate consumption was high, particularly in the third trimester.
  • Women who reported consuming more chocolate tended to be younger, less well educated, Hispanic, women who smoked during pregnancy, and women receiving prenatal care in clinics.
  • Of 1681 women, preeclampsia developed in 63 (3.7%).
  • Higher BMI, education, and nulliparity were most strongly associated with increased risk for preeclampsia.
  • Umbilical cord serum theobromine concentrations were negatively associated with preeclampsia (for the highest vs the lowest quartile [aOR, 0.31; CI, 0.11 - 0.87]).
  • Self-reported estimates of chocolate consumption were also negatively associated with preeclampsia.
  • The risk for preeclampsia was decreased for women consuming 5 or more servings of chocolate per week in the first 3 months of pregnancy vs women consuming less than 1 serving of chocolate weekly (aOR, 0.81; CI, 0.37 - 1.79).
  • The risk for preeclampsia was also decreased for women consuming 5 or more servings of chocolate per week in the last 3 months of pregnancy vs women consuming less than 1 serving of chocolate weekly (aOR, 0.60; CI, 0.30 - 1.24).
  • Limitations of this study include difficulty standardizing self-reported chocolate consumption, possible reverse causality, possible residual confounding by smoking or BMI, small number of women with preeclampsia, and potential misclassification of exposure.
  • Based on these findings, the investigators concluded that chocolate consumption during pregnancy may lower the risk for preeclampsia.
  • However, they recommend replication of these results in other large, prospective studies with a detailed evaluation of chocolate consumption, including the temporal relationship between chocolate consumption in pregnancy and subsequent preeclampsia.

Pearls for Practice

  • In this prospective cohort study of pregnant women, concentrations of umbilical cord serum theobromine, a marker for chocolate consumption, were negatively associated with preeclampsia.
  • Self-reported estimates of chocolate consumption were also negatively associated with preeclampsia in this study. The risk for preeclampsia was decreased by 19% for women consuming 5 or more servings per week vs women consuming less than 1 serving of chocolate weekly in the first 3 months of pregnancy. The risk for preeclampsia was decreased by 40% for women consuming 5 or more servings per week in the last 3 months of pregnancy vs women consuming less than 1 serving of chocolate weekly.

CME/CE Test

  • Print